Special Coverage: The Buck Institute for research on aging

Buck Institute could lose $3.2M under proposed NIH cuts

National Institutes of Health funding accounts for nearly half the $36 million budget of Novato’s Buck Institute for Research on Aging.

Stem-cell advance holds promise in treating blindness

Novato researchers used stem cells to generate photoreceptors then transplanted them into blind rodents.

The Buck’s new CEO tackles aging

Eric Verdin suggests aligning Novato’s The Buck Institute for Research on Aging with organizations that could transform local advances on chronic maladies of aging into human treatments.

Novato biotech goes public via reverse merger

A Novato biotech startup found its way to public stock trading by hooking up with a cigar company.

Novato startup fights Parkinson’s with stem cells

A company founder at the Buck Institute for Research on Aging in Novato has developed stem-cell lines expected to accelerate Parkinson’s disease research.

Novato biotech startup tackles arthritis, glaucoma

Unity Biotechnology First Company in February 2016 propelled into the public arena from its home at The Buck Institute for Research on Aging in Novato.

© The North Bay Business Journal  |  Terms of Service |  Privacy Policy |  Jobs With Us |  RSS |  Advertising |  Sonoma Media Investments
Switch to our Mobile View